Synonym

The page outlines a three-step process for vetting commercial CMOs for bioproduct manufacturing, including their ability to handle tech transfers, regulatory compliance, and global supply chains at commercial scale.

The page identifies three signs that a CMO may not support bioproduct scale-up: capacity limits, quality issues, and geographic barriers.

Brenntag, the global leader in chemicals and ingredients distribution, and Synonym, the production platform for biomaterials, have announced a strategic collaboration to fast-track bioproducts to the global market.

Synonym, the leading bioproduction platform announces the successful conclusion of a $20M Series A fundraising round. Co-led by GS Futures, the venture arm of GS Group, one of South Korea's largest conglomerates.

Bioproducts for a Better World

Synonym addresses high biomanufacturing costs by shifting from bespoke facility development to standardized project components. The company aims to reduce engineering expenses, accelerate development timelines, and improve access to lower-cost financing. These changes target scalable cost reductions across the bioindustrials sector.

Oct 2024World Bio Market InsightsNews article

SynBioBeta 2024 explores solutions to the **scale-cost paradox** in biomanufacturing, where production costs rise despite advancements in microbial, animal, or plant cell-based processes. The event highlights strategies like using **novel microbial hosts** and **engineering cells to increase productivity**. These approaches aim to lower costs while scaling up biomanufactured products, building on decades of progress since insulin’s 1982 approval via genetically engineered bacteria.

May 2024AgFunderNewsNews article

Synonym, a biomanufacturing financing and development platform, secures a $6.3 million pre-seed funding round. The investment is led by Andreessen Horowitz, Giant Ventures, and other venture firms including Blue Horizon, Siddhi Capital, FJ Labs, and Global Founders Capital. The capital will support Synonym’s growth in scaling biomanufacturing solutions.

Oct 2022Green QueenNews article

Synonym Biotechnologies secures **$6.3 million in pre-seed funding** from Andreessen Horowitz (a16z), Giant Ventures, Blue Horizon, and Thia Ventures. The New York-based company develops **bio-manufacturing platforms** for non-pharmaceutical uses and is now advancing its first **productized facility solutions**. The funding supports scaling its technology beyond early-stage development.

Oct 2022Inshorts - Stay InformedNews article